AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Grothey, A Schmoll, HJ
Citation: A. Grothey et Hj. Schmoll, New chemotherapy approaches in colorectal cancer, CURR OPIN O, 13(4), 2001, pp. 275-286

Authors: Kohne, CH Grothey, A Bokemeyer, C Bontke, N Aapro, M
Citation: Ch. Kohne et al., Chemotherapy in elderly patients with colorectal cancer, ANN ONCOL, 12(4), 2001, pp. 435-442

Authors: Dempke, W Rie, C Grothey, A Schmoll, HJ
Citation: W. Dempke et al., Cyclooxygenase-2: a novel target for cancer chemotherapy?, J CANC RES, 127(7), 2001, pp. 411-417

Authors: Fittkau, M Grothey, A Gerlach, R Schmoll, HJ
Citation: M. Fittkau et al., A low dose of ionizing radiation increases luminal release of intestinal peptidases in rats, J CANC RES, 127(2), 2001, pp. 96-100

Authors: Voigt, W Bulankin, A Muller, T Schoeber, C Grothey, A Hoang-Vu, C Schmoll, HJ
Citation: W. Voigt et al., Schedule-dependent antagonism of gemcitabine and cisplatin in human anaplastic thyroid cancer cell lines, CLIN CANC R, 6(5), 2000, pp. 2087-2093

Authors: Dempke, W Voigt, W Grothey, A Hill, BT Schmoll, HJ
Citation: W. Dempke et al., Cisplatin resistance and oncogene - a review, ANTI-CANC D, 11(4), 2000, pp. 225-236

Authors: Grothey, A Hashizume, R Ji, H Tubb, BE Patrick, CW Yu, DH Mooney, EE McCrea, PD
Citation: A. Grothey et al., C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines, ONCOGENE, 19(42), 2000, pp. 4864-4875

Authors: Dempke, W Von Poblozki, A Grothey, A Schmoll, HJ
Citation: W. Dempke et al., Human hematopoietic growth factors: Old lessons and new perspectives, ANTICANC R, 20(6D), 2000, pp. 5155-5164

Authors: Hasenburg, A Grothey, A Jaspers, V Gitsch, G Spatling, L
Citation: A. Hasenburg et al., Breast size as risk factor for tumor size at diagnosis, ANTICANC R, 20(3B), 2000, pp. 2041-2044

Authors: Grothey, A Hashizume, R Sahin, AA McCrea, PD
Citation: A. Grothey et al., Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer, BR J CANC, 83(7), 2000, pp. 870-873

Authors: Dempke, W Voigt, W Grothey, A Schmoll, HJ
Citation: W. Dempke et al., Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin, ANTI-CANC D, 10(6), 1999, pp. 545-549

Authors: Dempke, W Behrmann, C Schober, C Buchele, T Grothey, A Schmoll, HJ
Citation: W. Dempke et al., Diagnostic and therapeutic management of superior vena cava syndrome, MED KLIN, 94(12), 1999, pp. 681-684

Authors: Dempke, W Grothey, A Schmoll, HJ
Citation: W. Dempke et al., Therapeutic management of pleural and pericardial effusions, ONKOLOGIE, 22(6), 1999, pp. 526-529

Authors: Akimoto, T Kawabe, S Grothey, A Milas, L
Citation: T. Akimoto et al., Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas, CLIN EXP M, 17(2), 1999, pp. 171-176

Authors: Grothey, A Voigt, W Schober, C Muller, T Dempke, W Schmoll, HJ
Citation: A. Grothey et al., The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors, J CANC RES, 125(3-4), 1999, pp. 166-173

Authors: Schmoll, HJ Buchele, T Grothey, A Dempke, W
Citation: Hj. Schmoll et al., Where do we stand with 5-fluorouracil?, SEMIN ONCOL, 26(6), 1999, pp. 589-605
Risultati: 1-16 |